JP Stock MarketDetailed Quotes
2160 GNI Group
- 3300
- +230+7.49%
20min DelayMarket Closed Nov 29 15:30 JST
165.41BMarket Cap19.93P/E (Static)
3300High3005Low1.56MVolume3025Open3070Pre Close4.95BTurnover386552wk High3.30%Turnover Ratio50.12MShares153752wk Low145.55EPS TTM155.65BFloat Cap4070Historical High19.93P/E (Static)47.17MShs Float13Historical Low165.56EPS LYR9.61%Amplitude--Dividend TTM4.49P/B100Lot Size--Div YieldTTM
About GNI Group Company
GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.
Company Profile
Symbol2160
Company NameGNI Group
Founded2001-11-20
MarketTSE Growth
Employees840
Fiscal Year Ends12-31
AddressShinjuku Park Tower 3-7-1 Nishi-Shinjuku
Zip Code103-0023
Phone03-6214-3600
Websitewww.gnipharma.com
Company Executives
- Name
- Position
- Salary
- Dr. Ying Luo, PhD
- Director, Representative Executive Officer, President and Chief Executive Officer
- --
- Toshiya Kitagawa
- Director, Executive Officer and Chief Financial Officer
- --
- Sekitani Kazuki
- Director, Executive Officer and Chief Operating Officer
- --
- Ryosuke Matsui
- Director
- --
- Thomas Eastling
- Director
- --
- Zhang Ping
- Independent Director
- --
- Hideaki Sashiwa
- Independent Director
- --
- Kikuchi Kanako
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
JP
Overall
Symbol
Latest Price
% Chg
No Data